J. Goldman & Co LP

Holdings History for TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

Symbol: TXMD on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-0%	$0	0	-13,562	-100%	$2.61	Q4 2025
30 Sep 2025	0%	0%	$14,579	13,562	0		$1.07	Q3 2025
30 Jun 2025	0%	0%	$15,732	13,562	0		$1.16	Q2 2025
31 Mar 2025	0%	0%	$12,545	13,562	0		$0.93	Q1 2025
31 Dec 2024	0%	0%	$11,663	13,562	0		$0.86	Q4 2024
30 Sep 2024	0%	0%	$22,513	13,562	0		$1.66	Q3 2024
30 Jun 2024	0%	0%	$21,835	13,562	0		$1.61	Q2 2024
31 Mar 2024	0%	0%	$31,057	13,562	0		$2.29	Q1 2024
31 Dec 2023	0%	0%	$30,515	13,562	0		$2.25	Q4 2023
30 Sep 2023	0%	0%	$40,957	13,562	0		$3.02	Q3 2023
30 Jun 2023	0%	0%	$55,875	13,562	0		$4.12	Q2 2023
31 Mar 2023	0%	0%	$50,858	13,562	0		$3.75	Q1 2023
31 Dec 2022	0.01%	-0.03%	$75,812	13,562	-69,414	-84%	$5.59	Q4 2022
30 Sep 2022	0.04%	+0.04%	$551,000	82,976	+82,976	NEW	$6.64	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.